Spring 2018 Cycle Therapeutic Pipeline Program

the Therapeutic Pipeline Program supports Parkinson's disease therapeutic development along the pre-clinical and clinical path (both drug and non-pharmacological therapeutics, including gene therapy, biological, surgical and non-invasive approaches). Application should be relevant to: 

• Disease-modifying strategies
• Symptomatic strategies

Funding: $100,000- $500,000 (for pre clinical research) 

Duration: No fixed limit 

Research Authority due date: 17.9.17

Pre proposal (required) due date: 27.9.17

Full application due date: 23.1.18